New Delhi, Nov. 7 -- The initial public offering (IPO) of Curis Lifesciences opened for public subscription on Friday, November 7, and will remain so until Tuesday, November 11. The NSE SME IPO is a fresh issue of 21,50,000 shares of the face value of Rs.10 each, aimed at raising about Rs.27.52 crore, which it intends to use for capital expenditure, loan payment and working capital requirements.

By 11:30 am on Friday, the issue had seen an overall subscription of 1.13 times, with the retail portion booked 0.14 times, and the segment reserved for NIIs subscribed to 0.28 times. QIB's portion was booked 3.50 times.

1. Curis Lifesciences IPO GMP: According to market sources, the latest grey market premium (GMP) of Curis Lifesciences IPO was...